LondonMental illness strikes 1 in 3 pregnant women.
Intimate partner violence triples the risk, a meta-analysis found; prevalence ranges from 22% in Asia to 40% in South America.
Most low-income maternal health systems lack routine mental health screening — where the burden is highest.
Sources: Nature
THE HORMONAL SUBSTRATE
Pregnancy triples estrogen and raises progesterone tenfold, then both crash within 48 hours of delivery. No other physiological event in adult life produces a hormonal swing of that magnitude. The brain's serotonin and GABA systems, which both sex hormones modulate, are destabilized for months on either side of birth.
WHY META-ANALYSES MATTER
Individual prevalence studies of perinatal depression have ranged from 5% to 50% depending on the screening tool, cutoff score, and country. A meta-analysis pools the underlying patient data across dozens of studies, weights by sample size, and produces a single estimate with confidence intervals — the closest thing epidemiology has to a verdict.
THE EDINBURGH SCALE
Most perinatal screening worldwide uses the Edinburgh Postnatal Depression Scale, a 10-question instrument designed in 1987. It takes three minutes, requires no clinician, and outperforms standard depression scales in pregnancy because it deliberately excludes somatic symptoms — fatigue, appetite change, sleep disruption — that overlap with normal pregnancy.
THE GEOGRAPHIC INVERSION
Prevalence is highest in South America and sub-Saharan Africa; screening infrastructure is concentrated in Europe, North America, and East Asia. The countries with the most cases have the fewest psychiatrists per capita — Ethiopia has roughly one psychiatrist per million people; the UK has about 150 per million.
THE IPV LINK
Intimate partner violence in pregnancy is not a separate risk factor stacked on top of mental illness — it is a causal driver. Stress hormones (cortisol, CRH) cross the placenta; chronic activation of the maternal stress axis is associated with preterm birth and low birth weight independent of the mother's diagnosis. The harm compounds across two bodies.
THE TREATMENT DILEMMA
SSRIs cross the placenta. Untreated maternal depression also affects fetal development through cortisol exposure and reduced self-care. Both options carry risk; doing nothing is not the safe choice. Most guidelines now recommend continuing antidepressants through pregnancy when the depression is moderate or severe, a reversal of 1990s practice.